ArticleBMC research notes2026
Is COVID-19 associated with delayed treatment of road traffic injuries arriving at the emergency department?
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aims to determine the delay in treatment of road traffic injuries in the ED during the COVID-19 pandemic.
resultsOut of 373 RTI patients, the majority were males (312, 83.6%), and the mean ± SD age was 32.2 ± 17.4. Most injuries were fractures in the upper & lower limbs (236, 63.3%), and 302 (81.0%) underwent surgery. Of 373, 74 (19.8%) RTI patients were positive for COVID-19. The mean ± SD number of hours from ED arrival to treatment start in COVID-19 positive patients was 10.9 ± 6.7, while 6.4 ± 1.6 in negative patients. About 65% of the patients had a delay in treatment (n = 242). After 30 days of follow-up, 21 (5.6%) patients were dead. The adjusted odds of delay in treatment of RTI patients were 1.80 times (95% CI 1.27-2.45) in males compared to females. The adjusted odds of treatment delays in COVID-19 positive patients were 1.47 times (95% CI 1.13-1.92) compared to negative patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.